BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26896646)

  • 1. Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.
    Prado S; Beltrán M; Coiras M; Bedoya LM; Alcamí J; Gallego J
    Biochem Pharmacol; 2016 May; 107():14-28. PubMed ID: 26896646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small-molecule inhibitor of HIV-1 Rev function detected by a diversity screen based on RRE-Rev interference.
    Prado S; Beltrán M; Moreno Á; Bedoya LM; Alcamí J; Gallego J
    Biochem Pharmacol; 2018 Oct; 156():68-77. PubMed ID: 30071201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
    Modem S; Reddy TR
    J Cell Physiol; 2008 Jan; 214(1):14-9. PubMed ID: 17929250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-directed remodeling of the HIV-1 protein Rev orchestrates assembly of the Rev-Rev response element complex.
    Jayaraman B; Crosby DC; Homer C; Ribeiro I; Mavor D; Frankel AD
    Elife; 2014 Dec; 3():e04120. PubMed ID: 25486594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of small molecule modulators of HIV-1 Tat and Rev protein accumulation.
    Balachandran A; Wong R; Stoilov P; Pan S; Blencowe B; Cheung P; Harrigan PR; Cochrane A
    Retrovirology; 2017 Jan; 14(1):7. PubMed ID: 28122580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA helicase MOV10 functions as a co-factor of HIV-1 Rev to facilitate Rev/RRE-dependent nuclear export of viral mRNAs.
    Huang F; Zhang J; Zhang Y; Geng G; Liang J; Li Y; Chen J; Liu C; Zhang H
    Virology; 2015 Dec; 486():15-26. PubMed ID: 26379090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative dimerization of a stably folded protein directed by a flexible RNA in the assembly of the HIV Rev dimer-RRE stem II complex.
    Tanamura S; Terakado H; Harada K
    J Mol Recognit; 2016 May; 29(5):199-209. PubMed ID: 26620599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
    Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
    Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HIV-1 Rev and related inhibitors].
    Cao Y; Liu XY
    Yao Xue Xue Bao; 2007 Apr; 42(4):347-51. PubMed ID: 17633198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment and application of a screening anti-HIV-1 drug model targeted nuclear trafficking of virus RNA].
    Liu ZL; Li XY; Zhang Q; Jia PP; Yang L; Wei XL; Jiang JD; Cen S
    Yao Xue Xue Bao; 2010 Feb; 45(2):257-62. PubMed ID: 21351437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of an RNA Aptamer that Can Inhibit HIV-1 by Blocking Rev-Cognate RNA (RRE) Binding and Rev-Rev Association.
    Dearborn AD; Eren E; Watts NR; Palmer IW; Kaufman JD; Steven AC; Wingfield PT
    Structure; 2018 Sep; 26(9):1187-1195.e4. PubMed ID: 30017564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds.
    Zapp ML; Young DW; Kumar A; Singh R; Boykin DW; Wilson WD; Green MR
    Bioorg Med Chem; 1997 Jun; 5(6):1149-55. PubMed ID: 9222509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev function.
    Wong RW; Balachandran A; Haaland M; Stoilov P; Cochrane A
    Nucleic Acids Res; 2013 Nov; 41(20):9471-83. PubMed ID: 23945945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
    Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
    Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar Localization of HIV-1 Rev Is Required, Yet Insufficient for Production of Infectious Viral Particles.
    Arizala JAC; Takahashi M; Burnett JC; Ouellet DL; Li H; Rossi JJ
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):961-981. PubMed ID: 29804468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rev-ing up post-transcriptional HIV-1 RNA expression.
    Yedavalli VS; Jeang KT
    RNA Biol; 2011; 8(2):195-9. PubMed ID: 21358275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.